Agenda

Filters

Tracks
Experience

Sat Apr 10

7:15 - 7:45 AM (EST)

Orientation Session (Non-Accredited)

You don’t want to miss this engaging conference kick off. Our Conference Co-Chairs will provide insight into what you can expect to gain out of attending the conference. Hear about all the great things Psych Congress NP Institute has in store and learn how to get the most out of your conference experience.
Saturday, April 10 7:15–7:45 AM

8:00 - 9:10 AM (EST)

Breakfast Innovation Theater (Non-Accredited)

Breakfast will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.
Saturday, April 10 8:00–9:10 AM

Breakfast Innovation Theater (Non-Accredited)

Breakfast will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.
Saturday, April 10 8:00–9:10 AM

9:20 - 10:50 AM (EST)

Opening Session: Fundamental Insights into Neurobiology: From Brain Circuits to Better Patient Care

A strong understanding of neurobiology provides the foundation for thoughtful psychiatric assessment and treatment. This session examines the complex interplay among neurotransmitter systems, neural circuits, brain networks, and neuroplasticity that contributes to psychiatric symptoms and disorders. Faculty will connect foundational neuroscience with current advances in the field, translating complex concepts into clinically relevant insights that strengthen diagnostic reasoning, treatment selection, and psychopharmacologic decision-making.

Speaker

Saturday, April 10 9:20–10:50 AM
Co-Chair

Andrew Penn

MS, PMHNP-BC
Clinical Professor / Director of Clinical Nursing Operations
University of California, San Francisco, School of Nursing / Salma Health

Andrew Penn, MS, PMHNP is a Professor in the University of California, San Francisco, School of Nursing where his teaching has received the UCSF Academic Senate Distinction in Teaching Award, among other recognitions. Trained as a psychiatric/mental health nurse practitioner, he directs clinical nursing operations for Salma Health an early stage psychiatric interventional treatment clinical company. As a researcher, he has collaborated on psychedelics studies of psilocybin and MDMA in the Translational Psychedelics Research (TrPR) and the Carhart-Harris labs at UCSF. A leading voice in nursing, he is a cofounder of the Organization of Psychedelic and Entheogenic Nurses (OPENurses.org), advocating for the perspective of nurses in psychedelic therapy, he has published on psychedelics in the American Journal of Nursing, Frontiers in Psychiatry, The Journal of Humanistic Psychotherapy, and JAMA. An internationally invited speaker, he has lectured at SXSW, Aspen Health Ideas Festival, TEDx, the Singapore Ministry of Health, and Oxford University and can be found at Andrewpennnp.com.

11:00 - 12:00 PM (EST)

The Essential Guide to Mood Stabilizers for Bipolar Spectrum Disorder: Part One

Mood stabilizing medications are used in the treatment of a variety of different psychiatric illnesses including bipolar disorder, depression, and schizoaffective disorders. While there are a number of newer medications within this drug class, some agents such as lithium have been around since the 1940s and still have great clinical effectiveness. In this session, expert faculty will discuss available agents within this medication class, comparing mechanism of action, appropriate dosing, side effect management, and comorbid considerations.
Saturday, April 10 11:00–12:00 PM

12:10 - 1:10 PM (EST)

Masterclass

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of mental health conditions. Both seasoned and early-career mental health professionals will benefit from the knowledge and insights shared by our diverse team of expert clinical faculty. Complementing the overall agenda, these sessions provide a deep dive into emerging therapies, new treatment formulations, and management of the most complex patients, and are designed to answer your most challenging questions. Supported by educational grants and with a focus on translating current research into practical, real-world applications, these sessions will help you effectively integrate the latest advances in mental health care into clinical practice, enhancing your professional skills and improving patient outcomes.
Saturday, April 10 12:10–1:10 PM
1 Credits
MasterClass

Masterclass

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of mental health conditions. Both seasoned and early-career mental health professionals will benefit from the knowledge and insights shared by our diverse team of expert clinical faculty. Complementing the overall agenda, these sessions provide a deep dive into emerging therapies, new treatment formulations, and management of the most complex patients, and are designed to answer your most challenging questions. Supported by educational grants and with a focus on translating current research into practical, real-world applications, these sessions will help you effectively integrate the latest advances in mental health care into clinical practice, enhancing your professional skills and improving patient outcomes.
Saturday, April 10 12:10–1:10 PM
1 Credits
MasterClass

1:20 - 2:30 PM (EST)

Lunch Innovation Theater (Non-Accredited)

Lunch will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.
Saturday, April 10 1:20–2:30 PM

Lunch Innovation Theater (Non-Accredited)

Lunch will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.
Saturday, April 10 1:20–2:30 PM

2:40 - 3:40 PM (EST)

The Essential Guide to Mood Stabilizers for Bipolar Spectrum Disorder: Part Two

Mood stabilizing medications are used in the treatment of a variety of different psychiatric illnesses including bipolar disorder, depression, and schizoaffective disorders. While there are a number of newer medications within this drug class, some agents such as lithium have been around since the 1940s and still have great clinical effectiveness. In this session, expert faculty will discuss available agents within this medication class, comparing mechanism of action, appropriate dosing, side effect management, and comorbid considerations.
Saturday, April 10 2:40–3:40 PM

3:50 - 4:50 PM (EST)

Hormones, Mood, and Midlife: Practical Psychopharmacology for Perimenopause and Menopause

Perimenopause and menopause can bring hormonal changes that influence mood, cognition, attention, sleep, and the course of existing psychiatric conditions. This session explores the intersection of the menopausal transition with depression, PMDD, and ADHD, with an emphasis on recognizing changing symptom patterns and navigating complex treatment decisions. Through an integrated patient case and lived experience, faculty will examine practical psychopharmacologic strategies, hormone therapy considerations, differential diagnosis, and individualized approaches to help psychiatric NPs provide informed, patient-centered care during midlife.

Speaker

Saturday, April 10 3:50–4:50 PM
Faculty

Annmarie Kropp

DNP, FNP-C, PMHNP-BC, PMH-C
Co-Owner and Director of Clinical Operations
Zephyr Behavioral Health and Wellness

Annmarie Kropp, DNP, FNP-C, PMHNP-BC, PMH-C is a doctoral-prepared psychiatric nurse practitioner and the Founder of Zephyr Behavioral Health & Wellness in Colorado. Her work is grounded in the belief that mental health care should be thoughtful, accessible, and deeply human, meeting people where they are while providing evidence-based, individualized treatment.

Dr. Kropp provides psychiatric care across the lifespan, with clinical interests that include anxiety and depression, trauma-related conditions, ADHD, perinatal mental health, and treatment-resistant mood disorders. She is known for integrating innovative treatment options, such as ketamine-assisted therapy and neuromodulation, with comprehensive psychiatric care, strong safety protocols, and informed, collaborative decision-making.

In addition to clinical care, Dr. Kropp is deeply involved in program development and systems design, creating treatment pathways and educational resources that support patients, families, first responders, and fellow clinicians. Her work emphasizes continuity of care, ethical implementation of emerging treatments, and building sustainable behavioral health programs that prioritize both patient outcomes and provider well-being.

As a participant in the Psych Congress Elevate Emerging Voices program, Dr. Kropp brings a real-world clinical perspective to conversations about innovation in psychiatry, with a focus on translating emerging science into compassionate, practical care that supports long-term healing.

Faculty

Moushumi Mukerji

MSN, PMHNP-BC, CNM
Psychiatric Mental Health Nurse Practitioner; Certified Nurse Midwife
Hope Therapy and Psychiatry Center

Moushumi Mukerji MSN, PMHNP-BC, CNM is a psychiatric nurse practitioner in private practice with Hope Therapy and Psychiatry Center and Headway. She is also a certified nurse-midwife with 21 years of experience in midwifery, women’s health, and maternity care nursing in various settings around the country. In her clinical practice she provides medication management, psychotherapy, and ketamine-assisted psychotherapy. She specializes in perinatal and women's mental health. Moushumi is a graduate of the Yale University and University of California San Francisco Schools of Nursing. She is a volunteer faculty member of the University of California San Francisco School of Nursing as an Associate Clinical Professor. In her free time she enjoys travel, gardening, and meditating.

Beyond the Prescription: A Practical Introduction to Interventional Psychiatry

TMS, ketamine, and esketamine have expanded treatment options in psychiatric practice. Nurse practitioners need a practical understanding of these interventions to counsel patients, recognize appropriate referral opportunities, and coordinate care. This session introduces the mechanisms, evidence, and treatment experience associated with each approach. Faculty will discuss who to refer and when, with attention to treatment history, patient preferences, and clinical needs. The session will also examine access barriers, including insurance coverage, monitoring requirements, transportation, and workflow. A closing discussion will consider the practical demands of potential future psychedelic treatment delivery.

Speaker

Saturday, April 10 3:50–4:50 PM
Faculty

Michael Asbach

DMSc, PA-C
Associate Medical Director
DENT Neurologic Institute

Dr. Michael Asbach, DMSc, PA-C is a doctorally trained Physician Assistant and Associate Medical Director at the DENT Neurologic Institute in Buffalo, New York. He earned his Master’s in Physician Assistant Studies from Daemen University and his Doctor of Medical Science from A.T. Still University. He also holds the Psychiatry Certificate of Added Qualification from the National Commission on Certification of Physician Assistants.
A nationally recognized educator and CME speaker, Dr. Asbach specializes in treatment-resistant depression, bipolar disorder, and emerging psychiatric therapies. He holds a faculty appointment with Shenandoah University’s Doctor of Medical Science program, teaches across multiple universities, serves on the Psych Congress Steering Committee, and is a co-chair of the Psych Congress PA Institute annual meeting.

Dr. Asbach’s work bridges clinical innovation, professional advocacy, and disruption in healthcare, with a focus on advancing psychiatry, elevating the PA profession, and shaping the future of collaborative care.

Co-Chair

Chelsie Monroe

MSN, APN, PMHNP-BC
Founder
Balanced Mental Wellness

Chelsie Monroe is a board-certified Psychiatric Mental Health Nurse Practitioner and founder of a group private practice, Balanced Mental Wellness in Littleton, Colorado where she serves as medical director. She has over 15 years of experience working in a variety of settings including inpatient, outpatient, psychiatric emergency services, forensics, community mental health, and private practice settings. She specializes in complex trauma, forensics, addiction, and severe mental illnesses, and has special interest in psychedelic assisted therapies and entrepreneurial APN roles. Chelsie is board certified in Integrative Psychiatry, and is an expert in ketamine assisted psychotherapy (KAP). She is trained as a psychotherapist and believes the relationship is the key to being an excellent clinician.

4:50 - 5:50 PM (EST)

Opening Reception in the Exhibit Hall

Join your peers in the Exhibit Hall to engage and learn about available pharmaceuticals and devices for your practice. Hors d’oeuvres and beverages available.
Saturday, April 10 4:50–5:50 PM

6:00 - 7:10 PM (EST)

Dinner Innovation Theater (Non-Accredited)

Dinner will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.
Saturday, April 10 6:00–7:10 PM

Sun Apr 11

7:00 - 7:30 AM (EST)

Co-Chair Kick-Off: Your Unanswered Questions

Sunday, April 11 7:00–7:30 AM

7:40 - 8:50 AM (EST)

Breakfast Innovation Theater (Non-Accredited)

Breakfast will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.
Sunday, April 11 7:40–8:50 AM

9:00 - 10:00 AM (EST)

The Essential Guide to Oral Antidepressants For Major Depressive Disorder: Part One

Antidepressants are the most commonly prescribed psychiatric drug class, with a variety of options on the market with differing indications, including depression, anxiety, and more. It is important prescribers understand the differences between the available options. In this session, expert faculty will explore the psychopharmacology of antidepressants, looking at their mechanism of action, review the list of approved medications within this drug-class, and understand appropriate dosing and adverse effects.
Sunday, April 11 9:00–10:00 AM

10:10 - 11:40 AM (EST)

Exhibit Hall Break

Join your peers in the Exhibit Hall to engage with mentors, recruiters, and future employers, and learn about available pharmaceuticals and devices for your practice.
Sunday, April 11 10:10–11:40 AM

11:50 - 12:50 PM (EST)

Masterclass

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of mental health conditions. Both seasoned and early-career mental health professionals will benefit from the knowledge and insights shared by our diverse team of expert clinical faculty. Complementing the overall agenda, these sessions provide a deep dive into emerging therapies, new treatment formulations, and management of the most complex patients, and are designed to answer your most challenging questions. Supported by educational grants and with a focus on translating current research into practical, real-world applications, these sessions will help you effectively integrate the latest advances in mental health care into clinical practice, enhancing your professional skills and improving patient outcomes.
Sunday, April 11 11:50–12:50 PM
1 Credits
MasterClass

Masterclass

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of mental health conditions. Both seasoned and early-career mental health professionals will benefit from the knowledge and insights shared by our diverse team of expert clinical faculty. Complementing the overall agenda, these sessions provide a deep dive into emerging therapies, new treatment formulations, and management of the most complex patients, and are designed to answer your most challenging questions. Supported by educational grants and with a focus on translating current research into practical, real-world applications, these sessions will help you effectively integrate the latest advances in mental health care into clinical practice, enhancing your professional skills and improving patient outcomes.
Sunday, April 11 11:50–12:50 PM
1 Credits
MasterClass

1:00 - 2:10 PM (EST)

Lunch Innovation Theater (Non-Accredited)

Lunch will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.
Sunday, April 11 1:00–2:10 PM

Lunch Innovation Theater (Non-Accredited)

Lunch will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.
Sunday, April 11 1:00–2:10 PM

2:20 - 3:20 PM (EST)

The Essential Guide to Oral Antidepressants For Major Depressive Disorder: Part Two

Antidepressants are the most commonly prescribed psychiatric drug class, with a variety of options on the market with differing indications, including depression, anxiety, and more. It is important prescribers understand the differences between the available options. In this session, expert faculty will explore the psychopharmacology of antidepressants, looking at their mechanism of action, review the list of approved medications within this drug-class, and understand appropriate dosing and adverse effects.
Sunday, April 11 2:20–3:20 PM

3:30 - 4:30 PM (EST)

The Digital Practice: Delivering High-Quality Psychiatric Care in a Hybrid World

As psychiatric care increasingly spans in-person and virtual settings, clinicians must adapt their approach while maintaining quality, safety, and meaningful patient engagement. This session explores practical strategies for conducting effective telepsychiatric assessments, building therapeutic rapport virtually, managing safety and risk, and determining when virtual versus in-person care is most appropriate. Faculty will also address documentation, regulatory considerations, and practical approaches to creating a seamless, patient-centered hybrid model of psychiatric care.

Speaker

Sunday, April 11 3:30–4:30 PM
Faculty

Steven Krozer

PMHNP-BC, MSN, BSN, APRN
Founder and PMHNP-BC
itrust wellness

Steven J. Krozer, PMHNP-BC, is the founder of iTrust Wellness, a leading outpatient mental health clinic based in Greenville, South Carolina, and iTrust Cares, an outpatient geripsychiatry service that partners with assisted living, independent living, and skilled nursing facilities. Aside from founding these organizations, Steven maintains a robust weekly clinical caseload of patients and specializes in psychiatric medication management across a broad range of conditions, including depression, anxiety, ADHD, bipolar disorder, and PTSD. He earned his Master of Science in Nursing from Vanderbilt University and has built his clinical practice around evidence-based, measurement-driven care.

Steven’s approach to psychiatry is deeply patient-centered and education-forward. He believes that empowering patients with clear, understandable information is the foundation for better outcomes. His style of care simplifies complex psychiatric concepts without sacrificing scientific rigor, helping patients make informed decisions while achieving consistent, measurable results.

Driven by a passion to improve the provider and patient experience, Steven also founded iTrust Insights, a technology company creating solutions that reduce provider burnout, streamline workflows, and modernize mental health treatment through AI-driven tools and outcome tracking systems.

Inspired by a cross-country bike ride for mental health advocacy, Steven has dedicated his career to making high-quality psychiatric care accessible, understandable, and sustainable. Under his leadership, iTrust Wellness has expanded rapidly, offering in-person and telehealth services throughout the Carolinas.

Co-Chair

Desiree Matthews

PMHNP-BC
CEO
Different Mental Health Program

Desiree Matthews, MSN, PMHNP-BC is a board-certified psychiatric nurse practitioner and the founder of Different Mental Health Program, a multi-state telepsychiatry practice providing integrative, patient-centered psychiatric care. Her clinical work centers on the evaluation and treatment of schizophrenia and other psychotic disorders, mood disorders, ADHD, and the identification and management of drug-induced movement disorders.

Ms. Matthews is particularly interested in early intervention and longitudinal treatment planning for serious mental illness, with an emphasis on functional recovery and relapse prevention. Her professional interests include long-acting injectable antipsychotics, emerging pharmacologic treatments, and the responsible use of telehealth to expand access while maintaining high standards of care. In addition to her clinical practice, she is actively involved in clinician education and regularly presents on psychiatric treatment planning, practice sustainability, and navigating the evolving mental health care landscape.

4:30 - 5:30 PM (EST)

Exhibit Hall Reception

Join your peers in the Exhibit Hall to engage and learn about available pharmaceuticals and devices for your practice. Hors d’oeuvres and beverages available.
Sunday, April 11 4:30–5:30 PM

5:40 - 6:50 PM (EST)

Dinner Innovation Theater (Non-Accredited)

Dinner will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.
Sunday, April 11 5:40–6:50 PM

Mon Apr 12

7:00 - 7:30 AM (EST)

Co-Chair Kick-Off: Your Unanswered Questions

Monday, April 12 7:00–7:30 AM

7:40 - 8:50 AM (EST)

Breakfast Innovation Theater (Non-Accredited)

Breakfast will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.
Monday, April 12 7:40–8:50 AM

9:00 - 10:00 AM (EST)

The Essential Guide to Antipsychotics for Schizophrenia: Part One

Antipsychotics are a class of psychotropic medication broadly used to treat not only schizophrenia, but also schizoaffective disorder, bipolar disorder (mania, depression, and maintenance), agitation associated with Alzheimer's dementia, and as an augmentation strategy to treat major depressive disorder. In this session, expert faculty will review all available agents within this medication class, mechanisms of action, appropriate dosing of these agents, and adverse effects.
Monday, April 12 9:00–10:00 AM

10:10 - 11:40 AM (EST)

Exhibit Hall Break

Join your peers in the Exhibit Hall to engage with mentors, recruiters, and future employers, and learn about available pharmaceuticals and devices for your practice.
Monday, April 12 10:10–11:40 AM

11:50 - 12:50 PM (EST)

Masterclass

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of mental health conditions. Both seasoned and early-career mental health professionals will benefit from the knowledge and insights shared by our diverse team of expert clinical faculty. Complementing the overall agenda, these sessions provide a deep dive into emerging therapies, new treatment formulations, and management of the most complex patients, and are designed to answer your most challenging questions. Supported by educational grants and with a focus on translating current research into practical, real-world applications, these sessions will help you effectively integrate the latest advances in mental health care into clinical practice, enhancing your professional skills and improving patient outcomes.
Monday, April 12 11:50–12:50 PM
1 Credits
MasterClass

Masterclass

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of mental health conditions. Both seasoned and early-career mental health professionals will benefit from the knowledge and insights shared by our diverse team of expert clinical faculty. Complementing the overall agenda, these sessions provide a deep dive into emerging therapies, new treatment formulations, and management of the most complex patients, and are designed to answer your most challenging questions. Supported by educational grants and with a focus on translating current research into practical, real-world applications, these sessions will help you effectively integrate the latest advances in mental health care into clinical practice, enhancing your professional skills and improving patient outcomes.
Monday, April 12 11:50–12:50 PM
1 Credits
MasterClass

1:00 - 2:10 PM (EST)

Lunch Innovation Theater (Non-Accredited)

Lunch will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.
Monday, April 12 1:00–2:10 PM

Lunch Innovation Theater (Non-Accredited)

Lunch will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.
Monday, April 12 1:00–2:10 PM

2:20 - 3:20 PM (EST)

The Essential Guide to Antipsychotics for Schizophrenia: Part Two

Antipsychotics are a class of psychotropic medication broadly used to treat not only schizophrenia, but also schizoaffective disorder, bipolar disorder (mania, depression, and maintenance), agitation associated with Alzheimer's dementia, and as an augmentation strategy to treat major depressive disorder. In this session, expert faculty will review all available agents within this medication class, mechanisms of action, appropriate dosing of these agents, and adverse effects.
Monday, April 12 2:20–3:20 PM

3:30 - 4:30 PM (EST)

Sleep in Psychiatric Practice: Essentials of Sleep Assessment and Insomnia Management

Sleep disturbances are among the most common and impactful concerns encountered in psychiatric practice, influencing the presentation, treatment, and outcomes of nearly every mental health condition. This session provides a practical foundation in the assessment and management of insomnia and other common sleep disturbances, with an emphasis on recognizing underlying sleep disorders, differentiating primary and secondary insomnia, and selecting evidence-based behavioral and pharmacologic interventions. Through clinical cases, faculty will discuss strategies for incorporating sleep assessment into routine psychiatric care and improving patient outcomes through individualized treatment planning.

Speaker

Monday, April 12 3:30–4:30 PM
Co-Chair

Desiree Matthews

PMHNP-BC
CEO
Different Mental Health Program

Desiree Matthews, MSN, PMHNP-BC is a board-certified psychiatric nurse practitioner and the founder of Different Mental Health Program, a multi-state telepsychiatry practice providing integrative, patient-centered psychiatric care. Her clinical work centers on the evaluation and treatment of schizophrenia and other psychotic disorders, mood disorders, ADHD, and the identification and management of drug-induced movement disorders.

Ms. Matthews is particularly interested in early intervention and longitudinal treatment planning for serious mental illness, with an emphasis on functional recovery and relapse prevention. Her professional interests include long-acting injectable antipsychotics, emerging pharmacologic treatments, and the responsible use of telehealth to expand access while maintaining high standards of care. In addition to her clinical practice, she is actively involved in clinician education and regularly presents on psychiatric treatment planning, practice sustainability, and navigating the evolving mental health care landscape.

Co-Occurring Disorders: Practical Management of Substance Use and Serious Mental Illness

Co-occurring substance use and serious mental illness can complicate assessment, treatment selection, and long-term recovery. This session explores practical strategies for recognizing and managing substance use within the context of complex psychiatric illness, with an emphasis on integrated, patient-centered care. Faculty will review evidence-based pharmacologic approaches, harm reduction, motivational interviewing, and strategies for addressing treatment adherence and relapse while coordinating care across disciplines to support improved outcomes.

Speaker

Monday, April 12 3:30–4:30 PM
Faculty

Lydia Bartholow

DNP, PMHNP, CARN-AP, FIAAN
Medical Director
OHSU

Lydia Bartholow, DNP, PMHNP, CARN-AP, FIANN is a doctorally prepared psychiatric nurse practitioner specializing in addiction medicine and trauma-informed care. She is a Fellow of the International Society of Addictions Nursing and serves as Medical Director of a psychiatric emergency department in Portland, Oregon, focused on acute psychiatric and substance-use–related crises. Lydia has held medical leadership roles in both inpatient and outpatient settings, building systems of care for people who use substances. She is the recipient of multiple state and national awards for excellence in addiction medicine, leadership, and health equity, and speaks nationally on co-occurring disorders, harm reduction, and substance-use care system improvement. She lives in Portland, OR with too many animals and just the right number of plants.

Faculty

Matt Tierney

MS, NP, FAAN
Lead Nurse Practitioner, Opiate Treatment Outpatient Program (OTOP), San Francisco General Hospital
UCSF School of Medicine, Department of Psychiatry, Division of Substance Use And Addiction Medicine (DSAAM)

Matt Tierney is a Nurse Practitioner and active clinician at San Francisco General Hospital’s
Opiate Treatment Outpatient Program (OTOP). The focus of his work for nearly 30 years is
improving access to evidence-based addiction treatment locally, regionally and nationally, and
he has created and directed numerous novel clinical programs designed to increase care for
problematic substance use. Past roles include Medical Director of Inpatient Substance Use
Management at UCSF Health, Clinical Director of Substance Use Treatment and Education at
UCSF's Office of Population Health, and Director of San Francisco’s Office-based Buprenorphine
Induction Clinic (OBIC), the first clinic in the nation devoted solely to buprenorphine treatment
initiation and stabilization. He is Past President of the American Psychiatric Nurses Association
(APNA) and continues to represent APNA at the National Academies of Sciences Engineering
and Medicine on the Forum on Mental Health and Substance Use Disorders. In 2018 he was
named a Fellow of the American Academy of Nursing, where he serves on the Expert Panel on
Psychiatric Mental Health and Substance Use. With national advanced-practice certifications in
Addictions Nursing (CARN-AP), Adult Primary Care (ANP), and Psychiatric-Mental Health
(PMHNP), he has expertise in addressing both indivi

4:40 - 5:40 PM (EST)

Beyond the Hype: Psychedelics and the Future of Psychiatric Practice

Psychedelic therapies are generating significant attention as potential treatments for psychiatric conditions, but what does the evidence actually show? This session examines the emerging science surrounding psilocybin, MDMA, and other psychedelic therapies, including potential applications in depression, PTSD, and substance use disorders. Faculty will explore current evidence, safety and patient selection, therapeutic support, and the evolving regulatory landscape. Participants will leave better prepared to separate evidence from hype, respond to patient questions, and understand how these emerging therapies may shape the future of psychiatric practice.

Speaker

Monday, April 12 4:40–5:40 PM
Faculty

Saundra Jain

MA, PsyD, LPC
Adjunct Clinical Affiliate, University of Texas at Austin School of Nursing;
Private Practice, Austin, Texas

Saundra Jain, MA, PsyD, LPC, is an Adjunct Clinical Affiliate in the School of Nursing at The University of Texas at Austin and a psychotherapist in private practice. Dr. Jain is a co-creator of WILD 5 – A Proven Path to Wellness and co-author of The Science and Practice of Wellness: Interventions for Happiness, Enthusiasm, Resilience, and Optimism (HERO). She is the co-creator of the Psychedelics and Wellness Survey (PAWS), exploring the intersection between psychedelics and wellness. She is the co-host of the newly launched podcast Happy Human 3.0, which explores how modern humans can move beyond merely surviving 21st-century stressors and begin to flourish by integrating neuroscience, positive psychiatry, and compassionate, human-centered care.

In addition, Dr. Jain serves on the Psych Congress Steering Committee, helping guide educational priorities and identify emerging needs in mental health practice. She also teaches with Fluence Training, a leading provider of psychedelic education for mental health professionals, where she serves as faculty in their certification programs in Psychedelic Harm Reduction and Integration (PHRI) and Ketamine-Assisted Psychotherapy (KAP).

Co-Chair

Andrew Penn

MS, PMHNP-BC
Clinical Professor / Director of Clinical Nursing Operations
University of California, San Francisco, School of Nursing / Salma Health

Andrew Penn, MS, PMHNP is a Professor in the University of California, San Francisco, School of Nursing where his teaching has received the UCSF Academic Senate Distinction in Teaching Award, among other recognitions. Trained as a psychiatric/mental health nurse practitioner, he directs clinical nursing operations for Salma Health an early stage psychiatric interventional treatment clinical company. As a researcher, he has collaborated on psychedelics studies of psilocybin and MDMA in the Translational Psychedelics Research (TrPR) and the Carhart-Harris labs at UCSF. A leading voice in nursing, he is a cofounder of the Organization of Psychedelic and Entheogenic Nurses (OPENurses.org), advocating for the perspective of nurses in psychedelic therapy, he has published on psychedelics in the American Journal of Nursing, Frontiers in Psychiatry, The Journal of Humanistic Psychotherapy, and JAMA. An internationally invited speaker, he has lectured at SXSW, Aspen Health Ideas Festival, TEDx, the Singapore Ministry of Health, and Oxford University and can be found at Andrewpennnp.com.

5:40 - 6:40 PM (EST)

Poster Reception (Non-Accredited)

Join the Steering Committee, attendees, and peers for the official Psych Congress NP Institute poster reception including appetizers and refreshments.
Monday, April 12 5:40–6:40 PM

6:40 - 7:50 PM (EST)

Dinner Innovation Theater (Non-Accredited)

Dinner will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.
Monday, April 12 6:40–7:50 PM

Tue Apr 13

7:00 - 7:30 AM (EST)

Co-Chair Kick-Off: Your Unanswered Questions

Tuesday, April 13 7:00–7:30 AM

7:40 - 8:50 AM (EST)

Breakfast Innovation Theater (Non-Accredited)

Breakfast will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.
Tuesday, April 13 7:40–8:50 AM

9:00 - 10:00 AM (EST)

The Essential Guide to Prescription Stimulants and Non-Stimulant Therapies for ADHD

Prescription stimulants are an effective pharmacotherapeutic choice for the treatment of ADHD, and are frequently prescribed across the lifespan of patients with ADHD. As such, it is important to understand why and how these medications work and react within the body in order to optimize patient care. This session will explore the psychopharmacology of stimulants, looking at their mechanism of action, review the list of approved medications within this category. While prescription stimulants are a strong tool for providers treating ADHD, it is important to understand the alternative forms of care available. Non-stimulant treatment options for ADHD will also be explored.
Tuesday, April 13 9:00–10:00 AM

10:10 - 11:10 AM (EST)

Documentation, Coding, and Compliance: Practical Essentials for the Psychiatric NP

Accurate documentation and coding are essential to quality psychiatric care, yet evolving requirements and complex clinical encounters can make getting them right a challenge. This session will provide psychiatric NPs with practical guidance for documenting services, selecting appropriate codes, and meeting key compliance requirements in everyday practice. Faculty will address common documentation and coding pitfalls, strategies for supporting medical necessity, and considerations for reducing compliance and reimbursement risk. Participants will leave with actionable approaches to improve documentation efficiency, coding confidence, and compliance while keeping the focus on patient care.

Speaker

Tuesday, April 13 10:10–11:10 AM
Faculty

Steven Krozer

PMHNP-BC, MSN, BSN, APRN
Founder and PMHNP-BC
itrust wellness

Steven J. Krozer, PMHNP-BC, is the founder of iTrust Wellness, a leading outpatient mental health clinic based in Greenville, South Carolina, and iTrust Cares, an outpatient geripsychiatry service that partners with assisted living, independent living, and skilled nursing facilities. Aside from founding these organizations, Steven maintains a robust weekly clinical caseload of patients and specializes in psychiatric medication management across a broad range of conditions, including depression, anxiety, ADHD, bipolar disorder, and PTSD. He earned his Master of Science in Nursing from Vanderbilt University and has built his clinical practice around evidence-based, measurement-driven care.

Steven’s approach to psychiatry is deeply patient-centered and education-forward. He believes that empowering patients with clear, understandable information is the foundation for better outcomes. His style of care simplifies complex psychiatric concepts without sacrificing scientific rigor, helping patients make informed decisions while achieving consistent, measurable results.

Driven by a passion to improve the provider and patient experience, Steven also founded iTrust Insights, a technology company creating solutions that reduce provider burnout, streamline workflows, and modernize mental health treatment through AI-driven tools and outcome tracking systems.

Inspired by a cross-country bike ride for mental health advocacy, Steven has dedicated his career to making high-quality psychiatric care accessible, understandable, and sustainable. Under his leadership, iTrust Wellness has expanded rapidly, offering in-person and telehealth services throughout the Carolinas.

Faculty

Kevin Williams

MS, MPAS, PA-C
CEO and Lead Clinician
OnPoint Behavioral Health

Kevin N. Williams MS, MPAS, PA-C is the CEO and Lead Clinician at OnPoint Behavioral Health. He is a Physician Associate that specializes in Psychiatry and has a mission to provide care that is experienced, holistic, and compassionate. He holds two master degrees in Interdisciplinary Medical Sciences and Physician Assistant Studies from the University of South Florida and South University respectively. He has gained experience treating children, adolescents, and adults for the past 11 years in the areas of inpatient, outpatient, and long-term care. Kevin has 10 years of experience teaching as an Adjunct Professor at several institutions around the country. Kevin also has over 10 years in executive leadership experience and maintains a passion of educating others to lead with effective influence. He has participated in mission work abroad and has enjoyed volunteering in several organizations in the Tampa Bay community. He enjoys spending time with his family along with his hobbies of aviation and traveling abroad.

Medication and Meaning: Integrating Psychopharmacology and Psychotherapy for Better Outcomes

Effective psychiatric care involves more than selecting the right medication—it also requires understanding the patient’s goals, experiences, and readiness for change. This session explores practical ways to integrate psychopharmacology with psychotherapy-informed approaches to strengthen the therapeutic relationship and support better outcomes. Faculty will highlight strategies for incorporating motivational interviewing, shared decision-making, and therapeutic communication into medication management visits to improve engagement, adherence, and long-term recovery.

Speaker

Tuesday, April 13 10:10–11:10 AM
Faculty

Saundra Jain

MA, PsyD, LPC
Adjunct Clinical Affiliate, University of Texas at Austin School of Nursing;
Private Practice, Austin, Texas

Saundra Jain, MA, PsyD, LPC, is an Adjunct Clinical Affiliate in the School of Nursing at The University of Texas at Austin and a psychotherapist in private practice. Dr. Jain is a co-creator of WILD 5 – A Proven Path to Wellness and co-author of The Science and Practice of Wellness: Interventions for Happiness, Enthusiasm, Resilience, and Optimism (HERO). She is the co-creator of the Psychedelics and Wellness Survey (PAWS), exploring the intersection between psychedelics and wellness. She is the co-host of the newly launched podcast Happy Human 3.0, which explores how modern humans can move beyond merely surviving 21st-century stressors and begin to flourish by integrating neuroscience, positive psychiatry, and compassionate, human-centered care.

In addition, Dr. Jain serves on the Psych Congress Steering Committee, helping guide educational priorities and identify emerging needs in mental health practice. She also teaches with Fluence Training, a leading provider of psychedelic education for mental health professionals, where she serves as faculty in their certification programs in Psychedelic Harm Reduction and Integration (PHRI) and Ketamine-Assisted Psychotherapy (KAP).

Faculty

Stephanie Kress

DNP, PMHNP-BC, LCSW, NE-PMC, RYT-200
Founder|Psychiatric Nurse Practitioner
Purple Mountains Wellness

Stephanie Kress, DNP, APRN, PMHNP-BC, LCSW, NE-PMC, RYT-200 is a compassionate psychiatric mental health provider, nurse leader, yoga instructor, & professional speaker dedicated to safe, equitable, & patient-centered care, as well as clinician well-being. With over 20 years of combined experience in mental health care & philanthropic service, she brings a deeply holistic approach to healing that honors the whole person: mind, body, & spirit.

Stephanie's a doctorally-prepared ANCC board-certified Psychiatric Mental Health Nurse Practitioner & Licensed Clinical Social Worker practicing in Tennessee. She's the Founder of Purple Mountains Wellness, LLC, a private outpatient psychiatric practice dedicated to supporting healthcare professionals, including nursing students, medical residents, & experienced clinicians. Stephanie creates a supportive, affirming space where clinicians can prioritize their own mental health while navigating the unique demands of healthcare careers. Her clinical approach integrates evidence-based psychopharmacology and psychotherapy with complementary practices, including yoga & mindfulness, to promote sustainable mental wellness &resilience.

Stephanie also serves as adjunct faculty at Galen College of Nursing & practices as a psychiatric nurse practitioner at Diana Health, specializing in women’s health &reproductive psychiatry. She holds a BA in Psychology (summa cum laude) from Virginia Wesleyan University, an MSW with a clinical concentration from Norfolk State University, as well as a DNP, MSN, & NE-PMC from Vanderbilt University School of Nursing.

Outside of her professional roles, Stephanie enjoys time on the Emerald Coast, hiking, white water rafting, yoga, & meaningful connections with family and friends—experiences that ground her and inform her commitment to intentional living.

11:20 - 12:20 PM (EST)

Masterclass

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of mental health conditions. Both seasoned and early-career mental health professionals will benefit from the knowledge and insights shared by our diverse team of expert clinical faculty. Complementing the overall agenda, these sessions provide a deep dive into emerging therapies, new treatment formulations, and management of the most complex patients, and are designed to answer your most challenging questions. Supported by educational grants and with a focus on translating current research into practical, real-world applications, these sessions will help you effectively integrate the latest advances in mental health care into clinical practice, enhancing your professional skills and improving patient outcomes.
Tuesday, April 13 11:20–12:20 PM
1 Credits
MasterClass

Masterclass

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of mental health conditions. Both seasoned and early-career mental health professionals will benefit from the knowledge and insights shared by our diverse team of expert clinical faculty. Complementing the overall agenda, these sessions provide a deep dive into emerging therapies, new treatment formulations, and management of the most complex patients, and are designed to answer your most challenging questions. Supported by educational grants and with a focus on translating current research into practical, real-world applications, these sessions will help you effectively integrate the latest advances in mental health care into clinical practice, enhancing your professional skills and improving patient outcomes.
Tuesday, April 13 11:20–12:20 PM
1 Credits
MasterClass

12:30 - 1:40 PM (EST)

Lunch Innovation Theater (Non-Accredited)

Lunch will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.
Tuesday, April 13 12:30–1:40 PM

Lunch Innovation Theater (Non-Accredited)

Lunch will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.
Tuesday, April 13 12:30–1:40 PM

1:50 - 2:50 PM (EST)

Little Patients, Big Decisions: Practical Pediatric Psychopharmacology

Psychopharmacologic treatment in children and adolescents requires balancing evidence-based care with the unique developmental, safety, and family considerations of younger patients. This session explores practical approaches to medication selection, dosing, monitoring, and treatment optimization for common pediatric psychiatric disorders. Faculty will highlight age-specific considerations, managing adverse effects, navigating complex prescribing decisions, and engaging patients and caregivers in shared decision-making to support safe, individualized, and effective care.

Speaker

Tuesday, April 13 1:50–2:50 PM
Co-Chair

Julie Carbray

PhD, PMHNP-BC, PMHCNS-BC, FAAN
Clinical Professor of Psychiatry and Nursing
University of Illinois Chicago

Dr. Carbray holds her PhD (93) and Master of Science (88) degrees from Rush University, Chicago and her Bachelor of Science (87) degree from Purdue University in West Lafayette, Indiana. A Clinical Professor of Psychiatry and Nursing at the University of Illinois Chicago, she has been practicing as a Psychiatric Nurse Practitioner over 35 years. As UIC faculty, Dr. Carbray teaches course content in psychopharmacology, mood disorders, and development and therapeutic interventions with children and adolescents for students across various multidisciplinary programs. As the Director of the Pediatric Mood Disorder Clinic, Dr. Carbray leads the clinical program and multidisciplinary training and is a nationally recognized clinical expert in children and adolescents with mood disorders. Dr. Carbray holds a national reputation of excellence in serving families of children with mood disorders, and was recognized with the UIC Preceptor of the year award, the Karen Gousman Excellence in Nursing Award, the American Psychiatric Nurses Association Best Practices in an Outpatient Program for Bipolar Disorder Award, the UIC Inspire Award, the APNA Distinguished Service Award and the Susan McCabe psychopharmacology lectureship from the International Society of Psychiatric Nurses. Dr Carbray has presented her work nationally and internationally and across communities and organizations including the American Girl Company. With a particular focus on helping families to help their children with mood disorders, Dr. Carbray has engaged in programs of research that are investigating the psychopharmacology of mood disorders, neurobiology of mood disorders, and neurobiologically informed treatments and family response to childhood mood disorders.

Faculty

Paige Oliver

PMHNP-BC, FNP-C
Owner, Founder, and Nurse Practitioner
Blooming Minds Psychiatry

Paige is a dual board-certified Psychiatric Mental Health and Family Nurse Practitioner dedicated to providing care for the underserved populations in rural South Georgia. She is a passionate advocate for reducing mental health stigma and improving access to quality psychiatric care within her community.

She is the founder and owner of Blooming Minds Psychiatry in Thomasville, Georgia. Through both her clinical practice, speaking engagements, and her social media platforms, Paige works to break down mental health stigma and create a supportive, welcoming space for conversations around mental wellness.

Paige has seven years of experience treating children, adolescents, and adults across outpatient, community-based, and private practice psychiatric settings. Her approach emphasizes integrative, whole-person care combining evidence-based psychopharmacology, holistic strategies, and a strong patient–clinician partnership to support lasting mental wellness.

Paige has also spent time in Haiti teaching and working alongside local nurses, contributing to the advancement of nursing education and training. Outside of work, Paige loves spending time with her husband and two daughters. She enjoys gardening, thrifting and antiquing—especially curating eclectic pieces for her office—and caring for chickens and goats on her homestead.

The Aging Brain on Medications: Optimizing Psychiatric Care in Older Adults

Psychopharmacologic treatment in older adults requires careful consideration of age-related changes, medical comorbidities, cognitive health, and the risks associated with polypharmacy. This session explores practical, evidence-based strategies for selecting, dosing, monitoring, and deprescribing psychiatric medications in older patients. Faculty will address medication interactions, anticholinergic burden, fall and cognitive risks, and approaches to balancing symptom management with safety, function, and quality of life.

Speaker

Tuesday, April 13 1:50–2:50 PM
Faculty

Amber Hoberg

PMHNP-BC
Baptist Health Systems
Morning Star Family Medicine PLLC

Amber Hoberg is a dedicated Psychiatric Mental Health Nurse Practitioner (PMHNP-BC) with extensive experience spanning various clinical settings and populations. She holds a master’s degree in advanced practice nursing, specializing in Family Psychiatric Mental Health, obtained from the University of Texas Health Science Center at San Antonio in 2010. Her career is marked by a commitment to providing evidence-based, individualized psychiatric care to patients across the lifespan, including children/adolescents, adults, and geriatric populations.
Currently based in Hillsboro, Oregon, at Visionary Psychiatry, Amber serves as a PMHNP-BC, focusing on nursing home and group home settings. Her role includes collaborating with others on the treatment team to ensure comprehensive care and managing EMAR and e-Prescribing documentation. She also practices at Morning Star Family Medicine PLLC in Floresville, Texas, where she practices and manages medication regimens for residents across outpatient, nursing home, and group home settings. Here, she collaborates closely with case managers, nurses, and psychological care teams, overseeing care for a substantial patient load. Her diverse clinical background includes roles at Northeast/Downtown Baptist Hospital in San Antonio, where she manages acute psychiatric care in an inpatient setting, working closely with psychiatrists and medical staff to deliver comprehensive treatment plans.

Faculty

Brooke Kempf

PMHNP-BC
Adjunct Faculty
Indiana University Indianapolis

Brooke Kempf, PMHNP-BC, is a nationally recognized psychiatric-mental health nurse practitioner and educator with nearly three decades of experience providing direct patient care and advancing evidence-based mental health services.
She began her career at Hamilton Center in Terre Haute, Indiana, where she worked as a psychiatric nurse across multiple areas of the community mental health center. Her leadership earned her the Hamilton Award for Outstanding Staff Member and helped shape an outpatient care model now used across several sites.
Brooke earned her Master of Science in Nursing from Stony Brook University and is board-certified as a Psychiatric-Mental Health Nurse Practitioner through the American Nurses Credentialing Center. Her advanced certification expanded her clinical role to include medication management and psychiatric care as an outpatient provider, inpatient hospitalist, and Chief Nursing Officer. She also played a key role in integrating psychiatric services into Wabash Valley Health Center, expanding access to care for underserved communities.
In addition to her clinical and administrative leadership, Brooke serves as adjunct faculty in the PMHNP program at Indiana University Indianapolis, where she has taught Neuro-Psychopharmacology and serves as a clinical instructor. She has contributed to program development at George Washington University and received the DAISY Award for Extraordinary Nursing Faculty. Nationally, she serves on pharmaceutical advisory boards, the Psych Congress Steering Committee, and volunteers with the American Foundation for Suicide Prevention.

3:00 - 4:00 PM (EST)

From Evidence to Practice: Practical Considerations for Clinical Judgment and Challenging Conversations - Q&A Panel

This closing Q&A panel brings NP Institute faculty together to explore how emerging evidence, clinical experience, and patient preferences inform everyday decision-making in psychiatric practice. Through moderated discussion and audience questions, panelists will share practical approaches to navigating clinical uncertainty, recognizing when to seek consultation, and addressing challenging conversations about diagnoses, medications, and treatment expectations. Faculty will discuss communication, shared decision-making, and boundary-setting strategies that preserve the therapeutic relationship while supporting evidence-based care and patient safety. Attendees will leave with actionable insights to strengthen clinical judgment and translate key takeaways from the meeting into practice.

Speaker

Tuesday, April 13 3:00–4:00 PM
Co-Chair

Julie Carbray

PhD, PMHNP-BC, PMHCNS-BC, FAAN
Clinical Professor of Psychiatry and Nursing
University of Illinois Chicago

Dr. Carbray holds her PhD (93) and Master of Science (88) degrees from Rush University, Chicago and her Bachelor of Science (87) degree from Purdue University in West Lafayette, Indiana. A Clinical Professor of Psychiatry and Nursing at the University of Illinois Chicago, she has been practicing as a Psychiatric Nurse Practitioner over 35 years. As UIC faculty, Dr. Carbray teaches course content in psychopharmacology, mood disorders, and development and therapeutic interventions with children and adolescents for students across various multidisciplinary programs. As the Director of the Pediatric Mood Disorder Clinic, Dr. Carbray leads the clinical program and multidisciplinary training and is a nationally recognized clinical expert in children and adolescents with mood disorders. Dr. Carbray holds a national reputation of excellence in serving families of children with mood disorders, and was recognized with the UIC Preceptor of the year award, the Karen Gousman Excellence in Nursing Award, the American Psychiatric Nurses Association Best Practices in an Outpatient Program for Bipolar Disorder Award, the UIC Inspire Award, the APNA Distinguished Service Award and the Susan McCabe psychopharmacology lectureship from the International Society of Psychiatric Nurses. Dr Carbray has presented her work nationally and internationally and across communities and organizations including the American Girl Company. With a particular focus on helping families to help their children with mood disorders, Dr. Carbray has engaged in programs of research that are investigating the psychopharmacology of mood disorders, neurobiology of mood disorders, and neurobiologically informed treatments and family response to childhood mood disorders.

Co-Chair

Desiree Matthews

PMHNP-BC
CEO
Different Mental Health Program

Desiree Matthews, MSN, PMHNP-BC is a board-certified psychiatric nurse practitioner and the founder of Different Mental Health Program, a multi-state telepsychiatry practice providing integrative, patient-centered psychiatric care. Her clinical work centers on the evaluation and treatment of schizophrenia and other psychotic disorders, mood disorders, ADHD, and the identification and management of drug-induced movement disorders.

Ms. Matthews is particularly interested in early intervention and longitudinal treatment planning for serious mental illness, with an emphasis on functional recovery and relapse prevention. Her professional interests include long-acting injectable antipsychotics, emerging pharmacologic treatments, and the responsible use of telehealth to expand access while maintaining high standards of care. In addition to her clinical practice, she is actively involved in clinician education and regularly presents on psychiatric treatment planning, practice sustainability, and navigating the evolving mental health care landscape.

Co-Chair

Chelsie Monroe

MSN, APN, PMHNP-BC
Founder
Balanced Mental Wellness

Chelsie Monroe is a board-certified Psychiatric Mental Health Nurse Practitioner and founder of a group private practice, Balanced Mental Wellness in Littleton, Colorado where she serves as medical director. She has over 15 years of experience working in a variety of settings including inpatient, outpatient, psychiatric emergency services, forensics, community mental health, and private practice settings. She specializes in complex trauma, forensics, addiction, and severe mental illnesses, and has special interest in psychedelic assisted therapies and entrepreneurial APN roles. Chelsie is board certified in Integrative Psychiatry, and is an expert in ketamine assisted psychotherapy (KAP). She is trained as a psychotherapist and believes the relationship is the key to being an excellent clinician.

Co-Chair

Andrew Penn

MS, PMHNP-BC
Clinical Professor / Director of Clinical Nursing Operations
University of California, San Francisco, School of Nursing / Salma Health

Andrew Penn, MS, PMHNP is a Professor in the University of California, San Francisco, School of Nursing where his teaching has received the UCSF Academic Senate Distinction in Teaching Award, among other recognitions. Trained as a psychiatric/mental health nurse practitioner, he directs clinical nursing operations for Salma Health an early stage psychiatric interventional treatment clinical company. As a researcher, he has collaborated on psychedelics studies of psilocybin and MDMA in the Translational Psychedelics Research (TrPR) and the Carhart-Harris labs at UCSF. A leading voice in nursing, he is a cofounder of the Organization of Psychedelic and Entheogenic Nurses (OPENurses.org), advocating for the perspective of nurses in psychedelic therapy, he has published on psychedelics in the American Journal of Nursing, Frontiers in Psychiatry, The Journal of Humanistic Psychotherapy, and JAMA. An internationally invited speaker, he has lectured at SXSW, Aspen Health Ideas Festival, TEDx, the Singapore Ministry of Health, and Oxford University and can be found at Andrewpennnp.com.

4:00 - 4:10 PM (EST)

NP Institute 2027 Final Thoughts (Non-Accredited)

Speaker

Tuesday, April 13 4:00–4:10 PM
Co-Chair

Julie Carbray

PhD, PMHNP-BC, PMHCNS-BC, FAAN
Clinical Professor of Psychiatry and Nursing
University of Illinois Chicago

Dr. Carbray holds her PhD (93) and Master of Science (88) degrees from Rush University, Chicago and her Bachelor of Science (87) degree from Purdue University in West Lafayette, Indiana. A Clinical Professor of Psychiatry and Nursing at the University of Illinois Chicago, she has been practicing as a Psychiatric Nurse Practitioner over 35 years. As UIC faculty, Dr. Carbray teaches course content in psychopharmacology, mood disorders, and development and therapeutic interventions with children and adolescents for students across various multidisciplinary programs. As the Director of the Pediatric Mood Disorder Clinic, Dr. Carbray leads the clinical program and multidisciplinary training and is a nationally recognized clinical expert in children and adolescents with mood disorders. Dr. Carbray holds a national reputation of excellence in serving families of children with mood disorders, and was recognized with the UIC Preceptor of the year award, the Karen Gousman Excellence in Nursing Award, the American Psychiatric Nurses Association Best Practices in an Outpatient Program for Bipolar Disorder Award, the UIC Inspire Award, the APNA Distinguished Service Award and the Susan McCabe psychopharmacology lectureship from the International Society of Psychiatric Nurses. Dr Carbray has presented her work nationally and internationally and across communities and organizations including the American Girl Company. With a particular focus on helping families to help their children with mood disorders, Dr. Carbray has engaged in programs of research that are investigating the psychopharmacology of mood disorders, neurobiology of mood disorders, and neurobiologically informed treatments and family response to childhood mood disorders.

Co-Chair

Desiree Matthews

PMHNP-BC
CEO
Different Mental Health Program

Desiree Matthews, MSN, PMHNP-BC is a board-certified psychiatric nurse practitioner and the founder of Different Mental Health Program, a multi-state telepsychiatry practice providing integrative, patient-centered psychiatric care. Her clinical work centers on the evaluation and treatment of schizophrenia and other psychotic disorders, mood disorders, ADHD, and the identification and management of drug-induced movement disorders.

Ms. Matthews is particularly interested in early intervention and longitudinal treatment planning for serious mental illness, with an emphasis on functional recovery and relapse prevention. Her professional interests include long-acting injectable antipsychotics, emerging pharmacologic treatments, and the responsible use of telehealth to expand access while maintaining high standards of care. In addition to her clinical practice, she is actively involved in clinician education and regularly presents on psychiatric treatment planning, practice sustainability, and navigating the evolving mental health care landscape.

Co-Chair

Chelsie Monroe

MSN, APN, PMHNP-BC
Founder
Balanced Mental Wellness

Chelsie Monroe is a board-certified Psychiatric Mental Health Nurse Practitioner and founder of a group private practice, Balanced Mental Wellness in Littleton, Colorado where she serves as medical director. She has over 15 years of experience working in a variety of settings including inpatient, outpatient, psychiatric emergency services, forensics, community mental health, and private practice settings. She specializes in complex trauma, forensics, addiction, and severe mental illnesses, and has special interest in psychedelic assisted therapies and entrepreneurial APN roles. Chelsie is board certified in Integrative Psychiatry, and is an expert in ketamine assisted psychotherapy (KAP). She is trained as a psychotherapist and believes the relationship is the key to being an excellent clinician.

Co-Chair

Andrew Penn

MS, PMHNP-BC
Clinical Professor / Director of Clinical Nursing Operations
University of California, San Francisco, School of Nursing / Salma Health

Andrew Penn, MS, PMHNP is a Professor in the University of California, San Francisco, School of Nursing where his teaching has received the UCSF Academic Senate Distinction in Teaching Award, among other recognitions. Trained as a psychiatric/mental health nurse practitioner, he directs clinical nursing operations for Salma Health an early stage psychiatric interventional treatment clinical company. As a researcher, he has collaborated on psychedelics studies of psilocybin and MDMA in the Translational Psychedelics Research (TrPR) and the Carhart-Harris labs at UCSF. A leading voice in nursing, he is a cofounder of the Organization of Psychedelic and Entheogenic Nurses (OPENurses.org), advocating for the perspective of nurses in psychedelic therapy, he has published on psychedelics in the American Journal of Nursing, Frontiers in Psychiatry, The Journal of Humanistic Psychotherapy, and JAMA. An internationally invited speaker, he has lectured at SXSW, Aspen Health Ideas Festival, TEDx, the Singapore Ministry of Health, and Oxford University and can be found at Andrewpennnp.com.

Speakers on stage

Agenda Highlights

This conference will cover everything from traditional medications to what's new on the market now, filling any gaps in your education, as well as new developments. Medication classes such as antidepressants, antipsychotics, mood stabilizers, and stimulants will be covered in depth. Psychiatric disorders such as ADHD, anxiety, bipolar, depression, and schizophrenia will be explored. The conference will also cover important practice-management topics such as most common billing errors and documentation best practices.

Attendees interacting

CE Information

This educational activity is specifically designed for nurse practitioners, psychiatric nurses, and other healthcare professionals who seek to improve the care of patients with mental health disorders.

Back to top